Intersect ENT (XENT) Misses Q2 EPS by 9c, Revenues Beat

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. WCN
6. SPOT
7. BMY
8. SPY
9. FIX
10. TSCO

Go back to Intersect ENT (XENT) Misses Q2 EPS by 9c, Revenues Beat

Intersect ENT Reports Second Quarter 2020 Financial Results

August 4, 2020 7:00 AM EDT

MENLO PARK, Calif.--(BUSINESS WIRE)-- Intersect ENT, Inc. (Nasdaq: XENT), a company transforming care for patients with ear, nose and throat (ENT) conditions, today reported financial results for the second quarter ended June 30, 2020.

Second Quarter 2020 Overview

Revenue of $9.8 million in the second quarter of 2020, compared to $26.7 million in the second quarter of 2019 Strong sales trend reinforces confidence in sequential second half revenue growth Cash, Cash Equivalents and Short-term Investments of $135.8 million

Total revenue was $9.8 million for the second quarter of 2020 compared to $26.7 million for... More